UPDATE : Monday, December 16, 2019
상단여백
Crystal Genomics confirms efficacy of epigenetics-based pulmonary fibrosis treatment by Lee Han-soo 2019-10-01 11:21
‘Merck Korea unilaterally lays off employees’ by Kim Yun-mi 2019-10-01 11:09
Allergan to compensate breast implant recipients for damage by Lee Hye-seon 2019-09-30 15:33
Ranitidine recall taking heavy toll on pharmaceuticals by Jeong Sae-im 2019-09-30 15:16
Sale of Novartis’ conjunctivitis drug Pataday banned for 3 months by Lee Hye-seon 2019-09-30 11:25
라인
Investor trust in bio-industrialists sank due to latter’s unethical acts by Lee Han-soo 2019-09-27 15:11
Genexine sets up joint firm in Thailand by Lee Han-soo 2019-09-26 17:00
[Analysis] Successive failures throw Korean bioindustry's drug-developing ability into question by Lee Han-soo 2019-09-26 15:39
Pfizer’s leukemia therapy Besponsa to get insurance benefit by Kim Yun-mi 2019-09-26 11:26
'Xtandi emerges as convenient treatment option for prostate cancer patients' by Lee Han-soo 2019-09-25 17:39
라인
Huons, Lipac Oncology to co-develop bladder cancer treatment by Lee Han-soo 2019-09-25 11:18
AstraZeneca releases detailed results of P3 trial of SGLT2 inhibitor by Lee Han-soo 2019-09-24 18:08
Qurient enrolls patients for trials of atopy treatment by Lee Han-soo 2019-09-24 17:00
Hanmi’s US partner to unveil results of anticancer drug study by Lee Han-soo 2019-09-24 17:00
Why using end-to-end services should be part of a drug product strategy by Lee Han-soo 2019-09-24 16:54
라인
Helixmith's fails to end P3 trials of diabetic peripheral neuropathy treatment by Lee Han-soo 2019-09-24 16:38
Hwail, SupexBNP wins patent for neutropenia treatment in US by Lee Han-soo 2019-09-23 22:34
Drug firms uncertain about pricing of quadrivalent flu vaccines by Jeong Sae-im 2019-09-23 14:52
Roche’s Tecentriq becomes 1st immunotherapy to win indication for SCLC by Lee Han-soo 2019-09-23 13:28
‘Diabetes treatment Forxiga born as new heart drug in DAPA-HF study’ by Kim Yun-mi 2019-09-23 11:45
여백
여백
여백
Back to Top